Patent · US Active

CAB molecules

US8728470B2 · kind B2 · utility

0Cited by
11References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 2, 2011
Grant dateMay 20, 2014
Priority date—
Expiry dateMay 11, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to CAB molecules, ADEPT constructs directed against CEA, and their use in therapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.